241 related articles for article (PubMed ID: 35436499)
21. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of mouthwashes on reducing SARS-CoV-2 viral load in oral cavity: a systematic review and meta-analysis.
Ebrahimi T; Shamshiri AR; Alebouyeh M; Mohebbi SZ
BMC Oral Health; 2023 Jul; 23(1):443. PubMed ID: 37400836
[TBL] [Abstract][Full Text] [Related]
23. Povidone-Iodine as a Pre-Procedural Mouthwash to Reduce the Salivary Viral Load of SARS-CoV-2: A Systematic Review of Randomized Controlled Trials.
Garcia-Sanchez A; Peña-Cardelles JF; Ordonez-Fernandez E; Montero-Alonso M; Kewalramani N; Salgado-Peralvo AO; Végh D; Gargano A; Parra G; Guerra-Guajardo LI; Kozuma W
Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270569
[TBL] [Abstract][Full Text] [Related]
24. Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study.
Bezinelli LM; Corrêa L; Beyerstedt S; Franco ML; Rangel ÉB; Benítez CG; Hamerschlak N; Pinho JRR; Heller D; Eduardo FP
PeerJ; 2023; 11():e15080. PubMed ID: 38130922
[TBL] [Abstract][Full Text] [Related]
25. Virucidal efficacy of chlorhexidine: a systematic review.
Fernandez MDS; Guedes MIF; Langa GPJ; Rösing CK; Cavagni J; Muniz FWMG
Odontology; 2022 Apr; 110(2):376-392. PubMed ID: 34637092
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
[TBL] [Abstract][Full Text] [Related]
27. Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro.
Xu C; Wang A; Hoskin ER; Cugini C; Markowitz K; Chang TL; Fine DH
Pathogens; 2021 Mar; 10(3):. PubMed ID: 33804294
[TBL] [Abstract][Full Text] [Related]
28. The effect of mouthrinses on severe acute respiratory syndrome coronavirus 2 viral load: A systematic review.
Silva A; Azevedo M; Sampaio-Maia B; Sousa-Pinto B
J Am Dent Assoc; 2022 Jul; 153(7):635-648.e16. PubMed ID: 35287944
[TBL] [Abstract][Full Text] [Related]
29. Randomized clinical trial to assess the impact of oral intervention with cetylpyridinium chloride to reduce salivary SARS-CoV-2 viral load.
Tarragó-Gil R; Gil-Mosteo MJ; Aza-Pascual-Salcedo M; Alvarez MJL; Ainaga RR; Gimeno NL; Viñuales RF; Fernández YM; Marco JM; Bolsa EA; Sancho JB; Cajo SA; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Izquierdo-Useros N; Pociello VB; León R; Peris DS
J Clin Periodontol; 2023 Mar; 50(3):288-294. PubMed ID: 36345827
[TBL] [Abstract][Full Text] [Related]
30. Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review.
Lim NA; Teng O; Ng CYH; Bao LXY; Tambyah PA; Quek AML; Seet RCS
Ann Med; 2022 Dec; 54(1):1488-1499. PubMed ID: 35594333
[TBL] [Abstract][Full Text] [Related]
31. Use of mouthwashes against COVID-19 in dentistry.
Vergara-Buenaventura A; Castro-Ruiz C
Br J Oral Maxillofac Surg; 2020 Oct; 58(8):924-927. PubMed ID: 32859459
[TBL] [Abstract][Full Text] [Related]
32. Could mouth rinses be an adjuvant in the treatment of SARS-CoV-2 patients? An appraisal with a systematic review.
Gandhi G; Thimmappa L; Upadhya N; Carnelio S
Int J Dent Hyg; 2022 Feb; 20(1):136-144. PubMed ID: 34628705
[TBL] [Abstract][Full Text] [Related]
33. Virucidal activity in vitro of mouthwashes against a feline coronavirus type II.
Buonavoglia A; Camero M; Lanave G; Catella C; Trombetta CM; Gandolfi MG; Palazzo G; Martella V; Prati C
Oral Dis; 2022 Nov; 28 Suppl 2(Suppl 2):2492-2499. PubMed ID: 34739171
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2.
Ferrer MD; Barrueco ÁS; Martinez-Beneyto Y; Mateos-Moreno MV; Ausina-Márquez V; García-Vázquez E; Puche-Torres M; Giner MJF; González AC; Coello JMS; Rueda IA; Aubá JMV; Español CC; Velasco AL; Abad DS; García-Esteban S; Artacho A; López-Labrador X; Mira A
Sci Rep; 2021 Dec; 11(1):24392. PubMed ID: 34937855
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the effect of gargling with hydrogen peroxide and povidone-iodine on salivary viral load of SARS-CoV-2: A pilot randomized clinical trial.
Adl A; Sedigh-Shams M; Jamalidoust M; Rajabzadeh Z
Niger J Clin Pract; 2023 Apr; 26(4):391-396. PubMed ID: 37203101
[TBL] [Abstract][Full Text] [Related]
36. Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses.
Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
J Prosthodont; 2020 Aug; 29(7):599-603. PubMed ID: 32608097
[TBL] [Abstract][Full Text] [Related]
37. The short-term effect of different chlorhexidine forms versus povidone iodine mouth rinse in minimizing the oral SARS-CoV-2 viral load: An open label randomized controlled clinical trial study.
Natto ZS; Bakhrebah MA; Afeef M; Al-Harbi S; Nassar MS; Alhetheel AF; Ashi H
Medicine (Baltimore); 2022 Jul; 101(30):e28925. PubMed ID: 35905275
[TBL] [Abstract][Full Text] [Related]
38. Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial.
Sánchez Barrueco Á; Mateos-Moreno MV; Martínez-Beneyto Y; García-Vázquez E; Campos González A; Zapardiel Ferrero J; Bogoya Castaño A; Alcalá Rueda I; Villacampa Aubá JM; Cenjor Español C; Moreno-Parrado L; Ausina-Márquez V; García-Esteban S; Artacho A; López-Labrador FX; Mira A; Ferrer MD
Emerg Microbes Infect; 2022 Dec; 11(1):1833-1842. PubMed ID: 35796097
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of mouthwash on reducing salivary SARS-CoV-2 viral load and clinical symptoms: a systematic review and meta-analysis.
Zhang M; Meng N; Duo H; Yang Y; Dong Q; Gu J
BMC Infect Dis; 2023 Oct; 23(1):678. PubMed ID: 37821800
[TBL] [Abstract][Full Text] [Related]
40. Virucidal activity of oral care products against SARS-CoV-2
Komine A; Yamaguchi E; Okamoto N; Yamamoto K
J Oral Maxillofac Surg Med Pathol; 2021 Jul; 33(4):475-477. PubMed ID: 33643836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
